A citation-based method for searching scientific literature

Christopher E Nelson, Yaoying Wu, Matthew P Gemberling, Matthew L Oliver, Matthew A Waller, Joel D Bohning, Jacqueline N Robinson-Hamm, Karen Bulaklak, Ruth M Castellanos Rivera, Joel H Collier, Aravind Asokan, Charles A Gersbach. Nat Med 2019
Times Cited: 182



Yi-Li Min, Hui Li, Cristina Rodriguez-Caycedo, Alex A Mireault, Jian Huang, John M Shelton, John R McAnally, Leonela Amoasii, Pradeep P A Mammen, Rhonda Bassel-Duby, Eric N Olson. Sci Adv 2019
Times Cited: 114




List of shared articles



Times cited

Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives.
Mathilde Beaufils, Lauriane Travard, John Rendu, Isabelle Marty. Curr Pharm Des 2022
0

CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders.
Lihong Guan, Yawei Han, Ciqing Yang, Suxiang Lu, Jiang Du, Han Li, Juntang Lin. Mol Neurobiol 2022
3

Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges.
Eman A Taha, Joseph Lee, Akitsu Hotta. J Control Release 2022
6


CRISPR Therapeutics for Duchenne Muscular Dystrophy.
Esra Erkut, Toshifumi Yokota. Int J Mol Sci 2022
0

CRISPR-Cas9 Gene Therapy for Duchenne Muscular Dystrophy.
Cedric Happi Mbakam, Gabriel Lamothe, Guillaume Tremblay, Jacques P Tremblay. Neurotherapeutics 2022
2

Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice.
Dileep R Karri, Yu Zhang, Francesco Chemello, Yi-Li Min, Jian Huang, Jiwoong Kim, Pradeep P A Mammen, Lin Xu, Ning Liu, Rhonda Bassel-Duby,[...]. Mol Ther Nucleic Acids 2022
0

1


Restoration of dystrophin expression and correction of Duchenne muscular dystrophy by genome editing.
Tejal Aslesh, Esra Erkut, Toshifumi Yokota. Expert Opin Biol Ther 2021
3

Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
Britt Hanson, Matthew J A Wood, Thomas C Roberts. RNA Biol 2021
12


Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy.
Fernanda Fortunato, Rachele Rossi, Maria Sofia Falzarano, Alessandra Ferlini. J Clin Med 2021
15

Targeted genome editing in vivo corrects a Dmd duplication restoring wild-type dystrophin expression.
Eleonora Maino, Daria Wojtal, Sonia L Evagelou, Aiman Farheen, Tatianna W Y Wong, Kyle Lindsay, Ori Scott, Samar Z Rizvi, Elzbieta Hyatt, Matthew Rok,[...]. EMBO Mol Med 2021
5


Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing.
F Chemello, A C Chai, H Li, C Rodriguez-Caycedo, E Sanchez-Ortiz, A Atmanli, A A Mireault, N Liu, R Bassel-Duby, E N Olson. Sci Adv 2021
27

Toward the correction of muscular dystrophy by gene editing.
Eric N Olson. Proc Natl Acad Sci U S A 2021
13

Efficient precise in vivo base editing in adult dystrophic mice.
Li Xu, Chen Zhang, Haiwen Li, Peipei Wang, Yandi Gao, Nahush A Mokadam, Jianjie Ma, W David Arnold, Renzhi Han. Nat Commun 2021
15


Gene editing and modulation for Duchenne muscular dystrophy.
Anthony A Stephenson, Kevin M Flanigan. Prog Mol Biol Transl Sci 2021
2

A consolidated AAV system for single-cut CRISPR correction of a common Duchenne muscular dystrophy mutation.
Yu Zhang, Takahiko Nishiyama, Hui Li, Jian Huang, Ayhan Atmanli, Efrain Sanchez-Ortiz, Zhaoning Wang, Alex A Mireault, Pradeep P A Mammen, Rhonda Bassel-Duby,[...]. Mol Ther Methods Clin Dev 2021
3

CRISPR/Cas correction of muscular dystrophies.
Yu Zhang, Takahiko Nishiyama, Eric N Olson, Rhonda Bassel-Duby. Exp Cell Res 2021
2

Gene-editing, immunological and iPSCs based therapeutics for muscular dystrophy.
Shagun Singh, Tejpal Singh, Chaitanya Kunja, Navdeep S Dhoat, Narender K Dhania. Eur J Pharmacol 2021
0

Therapeutic Exon Skipping Through a CRISPR-Guided Cytidine Deaminase Rescues Dystrophic Cardiomyopathy in Vivo.
Jia Li, Kaiying Wang, Yuchen Zhang, Tuan Qi, Juanjuan Yuan, Lei Zhang, Han Qiu, Jinxi Wang, Huang-Tian Yang, Yi Dai,[...]. Circulation 2021
3